WalesOnline | Dr. Goede on Obinutuzumab Versus Rituximab in CLL OncLive Valentin Goede, MD, from the University Hospital Cologne and the German CLL Study Group, discusses the efficacy findings from the stage 2 CLL11 study that examined obinutuzumab (Gazyva; formally GA101) plus chlorambucil in patients with chronic ... New Drug Combo Potentially 'Practice Changing' in CLL Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future ... 'Exciting' leukaemia drug trial results published after Welsh hospital trials |
